Health Canada’s Proposed Cannabis Act – Bill C-45

cannabis flag

The second of three readings of Bill C-45 – “An Act respecting the legal access to cannabis and the control of its production, distribution and sale”, was still being debated in parliament, before the summer break.

The latest publication of the Cannabis Act is from the first reading and the stated objectives are “to prevent young persons from accessing cannabis, to protect public health and public safety by establishing strict product safety and product quality requirements …”

The debate in the second reading stems around the Canadian Medical Association (CMA)’s outburst that “legalizing weed will harm youth”.  In addition, other Big Pharma supporters, such as the editor in chief of the Canadian Medical Association Journal stating that the new legislation is not protecting Canada’s youth.

Other Big Pharma supporters, such as Health Canada, claim that not enough research and scientific evidence exists on the safety of cannabis.

A study by the institute for Clinical Evaluative Sciences found that an alarming number of school age youth have been diagnosed with ADHD and prescribed harmful antipsychotic drugs.

The Diagnostic & Statistical Manual (DSM 5) is the basis for the listing of mental disorders in the International Classification of Diseases and is used throughout the world. Most of the disorders contained in this manual are said to be caused by a chemical imbalance in the brain.

According to the Citizens Commission on Human Rights (CCHR), the theory that mental disorders are caused by a chemical imbalance in the brain is just an unproven opinion, not fact, since mental disorders are determined by votes, not science. Furthermore, “Governments, insurance companies and private individuals pay billions of dollars each year to psychiatrists in pursuit of cures that psyhiatrists admit do not exist”.

Numerous strains of cannabis have the medicinal health benefits of relieving anxiety, stress, depression and insomnia without any harmful side effects.  In fact, GW Pharma has filed numerous patents on the medicinal benefits of cannabinoids for mental health disorders and a number of diseases, including cancer.

Although prescription bensodiazepines (diazepam, doral, xanax, valium, ativan, etc), used to treat a number of mental disorders, are a leading cause of death in Canada, cannabis has the ability to replace a number of these prescription pills – without harmful side effects.

When doing your own research on the medicinal benefits of cannabis, there is the Big Pharma side vs. Mother Nature. You decide.

 

 

Forensic Testing using THC:CBD

pisstified

With the adoption of the United Nation’s Single Convention on Drug Control in 1971, it became necessary for the international forensic community to be able to differentiate “drug-type” cannabis from “fiber-type”.

Due to the restricted research and limited knowledge of cannabis at the time, the United Nations adopted and recommended the ratio of the two main constituents of cannabis -THC and CBD .  In other words, if the ratio of THC:CBD was greater than 1 – it was deemed a drug; if the ratio was less than one, the plant was deemed to be hemp.

Cannabis is finally being accepted as the medicinal plant it is and as countries move towards accepting recreational cannabis, why is the industry still only focused on the ratio of THC to CBD????

To emphasize the meaningless of the THC to CBD ratio, the following strain fingerprints are for your perusal:

Durban poison
Pure Sativa – uplifting and ability to focus, it relieves stress, fatigue, depression
la con 2
Indica – calming  – relieves stress, insomnia, depression
acdc 2
Sativa dominant – focused and energizing, it relieves seizures, stress, inflammation and pain
Sour Diesel 2
Sativa dominant – energizing – relieves stress, depression and pain

With the exception of the ACDC strain above, the cannabinoid – CBD (cannabidiol) is only present in trace amounts in the above strain fingerprints, relative to CBG, CBC and or THCV.

The above strain fingerprints not only disclose the major cannabinoids present in a given strain, it also discloses the terpenes that are present.  Terpenes and cannabinoids are produced in the heads of the glandular trichomes, produced during the flowering stage of unfertilized female plants.

For indepth research on cannabinoids and terpenes, the following e-book is available at Amazon  and provides indepth information on cannabinoids, terpenes, strain fingerprints, plus so much more.

cannabis medicine
e-book link here

The synergistic benefits of the plant’s naturally produced cannabinoids and terpenes provide a great deal of additional benefits relative to just THC or CBD. As consumers and patients of cannabis become more educated on the full potential of this plant, it is important to insist on reviewing the full strain footprint from licensed vendors. In this way, the quality of product should increase, along with indepth research on the medicinal qualities of this plant.